Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Spinal drug delivery.

T S Grabow1, D Derdzinski, P S Staats

  • 1The Johns Hopkins Hospital, Department of Anesthesiology & Critical Care Medicine, 550 N. Broadway, Suite 301, Baltimore, MD 21205, USA.

Current Pain and Headache Reports
|October 26, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pain management for special populations-pediatric, geriatric, and intensive care unit patients.

Journal of back and musculoskeletal rehabilitation·2014
Same author

Visceral pain: From physiology to clinical practice.

Journal of back and musculoskeletal rehabilitation·2014
Same author

Chronic Intrathecal Baclofen Administration for the Treatment of Severe Generalized Tetanus via a Synchromed Infusion Pump.

Neuromodulation : journal of the International Neuromodulation Society·2011
Same author

A method for training physicians to implant intrathecal catheters.

Neuromodulation : journal of the International Neuromodulation Society·2011
Same author

Education: the goal of the next decade.

Neuromodulation : journal of the International Neuromodulation Society·2011
Same author

Long-term intrathecal ziconotide therapy: a case study and discussion.

Neuromodulation : journal of the International Neuromodulation Society·2011
Same journal

Analysis of the Effectiveness of Injection-Based Minimally Invasive Treatment for Piriformis Syndrome: Clinical Outcomes and Anatomical Correlates.

Current pain and headache reports·2026
Same journal

A Systematic Review and Meta-Analysis of Randomized Controlled Trials of Epidural Regenerative Medicine Therapies in Managing Spinal Pain.

Current pain and headache reports·2026
Same journal

Artificial Intelligence in Neuropathic Pain: From Mechanisms to Neuromodulation and Regenerative Strategies.

Current pain and headache reports·2026
Same journal

Proposed Conditions for Pain Reprocessing Therapy Readiness: Beyond Phenotyping Neuroplastic Pain.

Current pain and headache reports·2026
Same journal

Treatment of Headache in Children and Adolescents with POTS.

Current pain and headache reports·2026
Same journal

Pediatric Headache in the Age of Social Media: A Topical Review.

Current pain and headache reports·2026
See all related articles

Current intrathecal drug therapy decisions for chronic pain lack standardized measures. This review summarizes existing intrathecal agents and explores novel approaches for improved pain management.

Area of Science:

  • Pain Management
  • Pharmacology
  • Neurosurgery

Background:

  • Clinical decisions for intrathecal drug therapy in chronic pain rely on limited, non-standardized evidence.
  • Existing studies are often uncontrolled and retrospective, hindering objective treatment evaluation.

Purpose of the Study:

  • To review current intrathecal therapies for chronic pain management.
  • To highlight the limitations of existing evidence and explore future innovations in intrathecal drug delivery.

Main Methods:

  • Literature review and synthesis of current knowledge on intrathecal drug therapies.
  • Categorization of agents including opioids, GABA agonists, alpha-2 agonists, local anesthetics, calcium channel antagonists, and combination therapies.
  • Exploration of emerging and novel intrathecal drug delivery approaches.

Related Experiment Videos

Main Results:

  • Intrathecal therapies encompass a range of agents, each with specific mechanisms of action.
  • Current evidence base for these therapies is limited by study design and lack of standardized outcome measures.
  • Novel approaches hold promise for revolutionizing intrathecal drug delivery and chronic pain treatment.

Conclusions:

  • There is a critical need for standardized outcome measures in evaluating intrathecal drug therapies for chronic pain.
  • A comprehensive understanding of current agents and ongoing research into novel delivery systems is essential for advancing pain management.
  • Future research should focus on well-controlled studies to establish evidence-based guidelines for intrathecal therapy.